CSCs can be identified by various functional assays, including tumor sphere formation, xenograft assays, or detection of specific cell-surface markers [e.g., CD44, CD24, Oct-4, and ALDH1 in the case of breast cancer stem cells (BCSCs)] [8]. The gene discussed is CD44; the disease is breast carcinoma.